hemoregulatory peptide 5b has been researched along with cytarabine in 6 studies
| Studies (hemoregulatory peptide 5b) | Trials (hemoregulatory peptide 5b) | Recent Studies (post-2010) (hemoregulatory peptide 5b) | Studies (cytarabine) | Trials (cytarabine) | Recent Studies (post-2010) (cytarabine) |
|---|---|---|---|---|---|
| 43 | 0 | 2 | 15,487 | 2,424 | 3,188 |
| Protein | Taxonomy | hemoregulatory peptide 5b (IC50) | cytarabine (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 7.533 | |
| E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, KA; Moser, MH; Paukovits, JB; Paukovits, WR | 2 |
| Moser, MH; Paukovits, JB; Paukovits, WR; Rutter, R | 1 |
| Binder, KA; Guigon, M; Hergl, A; Laerum, OD; Paukovits, WR; Schulte-Hermann, R | 1 |
| Moser, MH; Paukovits, JB; Paukovits, WR | 1 |
| Konstantinov, S; Moser, MH; Paukovits, JB; Paukovits, WR; Schulte-Hermann, R | 1 |
1 review(s) available for hemoregulatory peptide 5b and cytarabine
| Article | Year |
|---|---|
The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Mice; Neutropenia; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid | 1990 |
5 other study(ies) available for hemoregulatory peptide 5b and cytarabine
| Article | Year |
|---|---|
Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.
Topics: Animals; Cytarabine; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Mice; Mice, Inbred BALB C; Mustard Compounds; Myeloproliferative Disorders; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |
Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.
Topics: Animals; Cell Division; Colony-Forming Units Assay; Cytarabine; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Kinetics; Mice; Mice, Inbred BALB C; Neutropenia; Oligopeptides; Pyrrolidonecarboxylic Acid | 1991 |
Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Colony-Stimulating Factors; Cytarabine; Female; Hematopoietic Stem Cells; Mice; Mice, Inbred BALB C; Oligopeptides; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1990 |
Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK).
Topics: Amino Acid Sequence; Animals; Cell Division; Cell Survival; Cytarabine; Female; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Interphase; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Oligopeptides; Pyrrolidonecarboxylic Acid | 1993 |
Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
Topics: Animals; Bone Marrow; Cell Division; Cytarabine; Dimerization; Doxorubicin; Female; Granulocytes; Hematopoiesis; Hematopoietic Stem Cells; Mice; Mice, Inbred BALB C; Models, Biological; Oligopeptides; Oxidation-Reduction; Pyrrolidonecarboxylic Acid; Reactive Oxygen Species; Specific Pathogen-Free Organisms; Sulfhydryl Compounds | 1998 |